{"id":250880,"date":"2022-06-20T00:00:00","date_gmt":"2022-06-20T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/epidcg0093-biopharma-parkinsons-disease-epidemiology-americas\/"},"modified":"2026-03-31T10:39:15","modified_gmt":"2026-03-31T10:39:15","slug":"epidcg0093-biopharma-parkinsons-disease-epidemiology-americas","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidcg0093-biopharma-parkinsons-disease-epidemiology-americas\/","title":{"rendered":"Parkinson&#8217;s Disease &#8211; Epidemiology &#8211; Americas"},"content":{"rendered":"<p>Clarivate Epidemiology\u2019s coverage of Parkinson\u2019s disease (<abbr title=\"Parkinson's disease\">PD<\/abbr>) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the diagnosed incidence and diagnosed prevalence of <abbr title=\"Parkinson's disease\">PD<\/abbr> for each country, as well as annualized case counts projected to the national population.<\/p>\n<p>Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and 10 years for the remaining countries covered in this report.<\/p>\n<p>Clarivate Epidemiology\u2019s <abbr title=\"Parkinson's disease\">PD<\/abbr> forecast will answer the following questions:<\/p>\n<ul class=\"round-bullets\">\n<li>Of all people diagnosed with <abbr title=\"Parkinson's disease\">PD<\/abbr>, how many in each country are drug-treated?<\/li>\n<li>How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of <abbr title=\"Parkinson's disease\">PD<\/abbr> over the forecast period?<\/li>\n<\/ul>\n<p>All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n<p>Clarivate Epidemiology provides at least 10 years of forecast data for the following <abbr title=\"Parkinson's disease\">PD<\/abbr> patient populations:<\/p>\n<ul class=\"round-bullets\">\n<li>Diagnosed prevalent cases of <abbr title=\"Parkinson's disease\">PD<\/abbr>.<\/li>\n<li>Diagnosed incident cases of <abbr title=\"Parkinson's disease\">PD<\/abbr>.<\/li>\n<li>Diagnosed prevalent cases of <abbr title=\"Parkinson's disease\">PD<\/abbr> with specific comorbidities (e.g., dementia, psychosis).<\/li>\n<li>Diagnosed prevalent cases of <abbr title=\"Parkinson's disease\">PD<\/abbr> by Hoehn and Yahr staging.<\/li>\n<li>Diagnosed prevalent cases of <abbr title=\"Parkinson's disease\">PD<\/abbr> by freezing of gait.<\/li>\n<li>Diagnosed prevalent cases of <abbr title=\"Parkinson's disease\">PD<\/abbr> by <abbr data-abbreviation-entity=\"6842\" title=\"leucine-rich repeat kinase 2\">LRRK2<\/abbr> mutation.<\/li>\n<li>Diagnosed prevalent cases of <abbr title=\"Parkinson's disease\">PD<\/abbr> by <abbr data-abbreviation-entity=\"6841\" title=\"glucocerebrosidase\">GBA<\/abbr> mutation.<\/li>\n<li>Diagnosed prevalent cases of <abbr title=\"Parkinson's disease\">PD<\/abbr> by drug-treatment status.<\/li>\n<\/ul>\n<p>Note: Coverage may vary by country and region.<\/p>\n","protected":false},"template":"","class_list":["post-250880","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-neurology","biopharma-therapy-areas-parkinsons-disease","biopharma-product-epidemiology","biopharma-date-960"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/250880","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/250880\/revisions"}],"predecessor-version":[{"id":283218,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/250880\/revisions\/283218"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=250880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}